Analyze O O O O
the O O O O
basic O O O O
information, O O O O
symptoms, O O O O
therapeutic O O O O
method O O O O
and O O O O
therapeutic O O O O
effect O O O O
of O O O O
novel O O O O
coronavirus O O O O
(COVID-19) O O O O
infected O O O O
pneumonia O O O O
patients O O O O
in O O O O
the O O O O
hospital O O O O
in O O O O
northern O O O O
Henan O O O O
Province O O O O
from O O O O
January O O O O
2020 O O O O
to O O O O
April O O O O
2020, O O O O
to O O O O
provide O O O O
evidences O O O O
for O O O O
prevention O O O O
and O O O O
treatment O O O O
of O O O O
COVID-19 O O O O
infectious O O O O
pneumonia. O O O O
Methods: O O O O
The O O O O
information O O O O
of O O O O
patients O O O O
of O O O O
COVID-19 O O O O
infectious O O O O
pneumonia O O O O
in O O O O
the O O O O
hospital O O O O
were O O O O
collected O O O O
and O O O O
analyzed, O O O O
including O O O O
the O O O O
admission O O O O
time, O O O O
the O O O O
discharge O O O O
time, O O O O
therapeutic O O O O
method, O O O O
and O O O O
therapeutic O O O O
effect O O O O
after O O O O
treatment. O O O O
Results: O O O O
A O O O O
total O O O O
of O O O O
10 O O O O
cases O O O O
patients O O O O
of O O O O
COVID-19 O O O O
infectious O O O O
pneumonia O O O O
were O O O O
collected, O O O O
there O O O O
were O O O O
5 O O O O
male O O O O
patients O O O O
and O O O O
5 O O O O
female O O O O
patients, O O O O
the O O O O
age O O O O
ranged O O O O
from O O O O
16-54 O O O O
years O O O O
old O O O O
and O O O O
the O O O O
average O O O O
age O O O O
was O O O O
34.2 O O O O
years O O O O
old; O O O O
the O O O O
body O O O O
temperature O O O O
of O O O O
6 O O O O
cases O O O O
patients O O O O
were O O O O
higher O O O O
than O O O O
37Â°C O O O O
when O O O O
they O O O O
were O O O O
admitted O O O O
to O O O O
hospital; O O O O
CT O O O O
results O O O O
showed O O O O
that O O O O
all O O O O
the O O O O
patients O O O O
had O O O O
infectious O O O O
lesions O O O O
of O O O O
both O O O O
lungs, O O O O
and O O O O
the O O O O
results O O O O
of O O O O
nucleic O O O O
acid O O O O
test O O O O
were O O O O
positive. O O O O
5 Reason 5 O O
million Reason 5 O O
(aerosol Reason 5 O O
inhalation) Reason 5 O O
recombinant Reason 5 O O
interferon Reason 5 O O
(Lopinavir/Ritonavir Reason 5 O O
or Reason 5 O O
Lopinavir/Ritonavir/Abidol) Reason 5 O O
combined Reason 5 O O
with Reason 5 O O
traditional Reason 5 O O
Chinese Reason 5 O O
medicine Reason 5 O O
could Reason 5 O O
alleviate Reason 5 O O
effectively Reason 5 O O
symptoms Reason 5 O O
of Reason 5 O O
COVID-19 Reason 5 O O
infectious Reason 5 O O
pneumonia Reason 5 O O
within Reason 5 O O
a Reason 5 O O
month, Reason 5 O O
the Reason 5 O O
body Reason 5 O O
temperature Reason 5 O O
of Reason 5 O O
patients Reason 5 O O
returned Reason 5 O O
to Reason 5 O O
normal, Reason 5 O O
respiratory Reason 5 O O
symptoms Reason 5 O O
improved Reason 5 O O
significantly, Reason 5 O O
COVID-19 Reason 5 O O
nucleic Reason 5 O O
acid Reason 5 O O
test Reason 5 O O
was Reason 5 O O
negative, Reason 5 O O
and Reason 5 O O
results Reason 5 O O
of Reason 5 O O
lung Reason 5 O O
imaging Reason 5 O O
was Reason 5 O O
also Reason 5 O O
normal. Reason 5 O O
Conclusion: O O O O
Lopinavir/Ritonavir Reason 4 O O
or Reason 4 O O
Lopinavir/Ritonavir/Abidol Reason 4 O O
combined Reason 4 O O
with Reason 4 O O
Traditional Reason 4 O O
Chinese Reason 4 O O
medicine Reason 4 O O
has Reason 4 O O
a Reason 4 O O
good Reason 4 O O
effect Reason 4 O O
on Reason 4 O O
relieving Reason 4 O O
the Reason 4 O O
symptoms Reason 4 O O
of Reason 4 O O
COVID-19 Reason 4 O O
infected Reason 4 O O
pneumonia Reason 4 O O
and Reason 4 O O
has Reason 4 O O
significance Reason 4 O O
for Reason 4 O O
clinical Reason 4 O O
treatment Reason 4 O O
or Reason 4 O O
clinic Reason 4 O O
remission Reason 4 O O
of Reason 4 O O
COVID-19 Reason 4 O O
infectious Reason 4 O O
pneumonia. Reason 4 O O
